These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30057321)

  • 1. Prophylactic effect of sulfasalazine against Pneumocystis pneumonia in patients with rheumatoid arthritis: A nested case-control study.
    Nunokawa T; Yokogawa N; Shimada K; Sugii S; Nishino J; Gosho M; Wagatsuma Y; Tohma S
    Semin Arthritis Rheum; 2019 Feb; 48(4):573-578. PubMed ID: 30057321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of sulfasalazine use on the presence of Pneumocystis organisms in the lung among patients with rheumatoid arthritis: A test-negative design case-control study with PCR tests.
    Nunokawa T; Yokogawa N; Shimada K; Sugii S
    Mod Rheumatol; 2019 May; 29(3):436-440. PubMed ID: 29652202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of sulfasalazine for the prevention of Pneumocystis pneumonia in patients with rheumatoid arthritis: A multicentric self-controlled case series study.
    Nunokawa T; Chinen N; Shimada K; Kimura M; Tateishi M; Chen FY; Setoguchi K; Sugihara M
    J Infect Chemother; 2023 Feb; 29(2):193-197. PubMed ID: 36334836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic antibiotic usage for Pneumocystis jirovecii pneumonia in patients with systemic lupus erythematosus on cyclophosphamide: a survey of US rheumatologists and the review of literature.
    Gupta D; Zachariah A; Roppelt H; Patel AM; Gruber BL
    J Clin Rheumatol; 2008 Oct; 14(5):267-72. PubMed ID: 18679133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumocystis jirovecii pneumonia in autoimmune rheumatic diseases: a nationwide population-based study.
    Hsu HC; Chang YS; Hou TY; Chen LF; Hu LF; Lin TM; Chiou CS; Tsai KL; Lin SH; Kuo PI; Chen WS; Lin YC; Chen JH; Chang CC
    Clin Rheumatol; 2021 Sep; 40(9):3755-3763. PubMed ID: 33646447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumocystis jirovecii pneumonia in solid organ transplant recipients: a descriptive analysis for the Swiss Transplant Cohort.
    Neofytos D; Hirzel C; Boely E; Lecompte T; Khanna N; Mueller NJ; Boggian K; Cusini A; Manuel O; van Delden C;
    Transpl Infect Dis; 2018 Dec; 20(6):e12984. PubMed ID: 30155950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumocystis jirovecii pneumonia in systemic autoimmune rheumatic disease: A case-control study.
    Tadros S; Teichtahl AJ; Ciciriello S; Wicks IP
    Semin Arthritis Rheum; 2017 Jun; 46(6):804-809. PubMed ID: 27814896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and risk factors of Pneumocystis jirovecii pneumonia in Korean patients with inflammatory bowel disease.
    Nam K; Park SH; Lee J; Jo S; Kim SO; Noh S; Park JC; Kim JY; Kim J; Ham NS; Oh EH; Song EM; Hwang SW; Yang DH; Ye BD; Byeon JS; Myung SJ; Yang SK
    J Gastroenterol Hepatol; 2020 Feb; 35(2):218-224. PubMed ID: 31412420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial.
    van Vollenhoven RF; Ernestam S; Geborek P; Petersson IF; Cöster L; Waltbrand E; Zickert A; Theander J; Thörner A; Hellström H; Teleman A; Dackhammar C; Akre F; Forslind K; Ljung L; Oding R; Chatzidionysiou A; Wörnert M; Bratt J
    Lancet; 2009 Aug; 374(9688):459-66. PubMed ID: 19665644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk and severity of herpes zoster in patients with rheumatoid arthritis receiving different immunosuppressive medications: a case-control study in Asia.
    Liao TL; Chen YM; Liu HJ; Chen DY
    BMJ Open; 2017 Jan; 7(1):e014032. PubMed ID: 28057661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumocystis jirovecii pneumonia (PJP) prophylaxis patterns among patients with rheumatic diseases receiving high-risk immunosuppressant drugs.
    Schmajuk G; Jafri K; Evans M; Shiboski S; Gianfrancesco M; Izadi Z; Patterson SL; Aggarwal I; Sarkar U; Dudley RA; Yazdany J
    Semin Arthritis Rheum; 2019 Jun; 48(6):1087-1092. PubMed ID: 30449650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphopenia is associated with late onset Pneumocystis jirovecii pneumonia in solid organ transplantation.
    Werbel WA; Ison MG; Angarone MP; Yang A; Stosor V
    Transpl Infect Dis; 2018 Jun; 20(3):e12876. PubMed ID: 29512868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No increased risk of herpes zoster in TNF inhibitor and non-TNF inhibitor users with rheumatoid arthritis: epidemiological study using the Japanese health insurance database.
    Sakai R; Kasai S; Hirano F; Harada S; Kihara M; Yokoyama W; Tsutsumino M; Nagasaka K; Koike R; Yamanaka H; Miyasaka N; Harigai M
    Int J Rheum Dis; 2018 Sep; 21(9):1670-1677. PubMed ID: 29667330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low incidence of Pneumocystis jirovecii pneumonia in an unprophylaxed liver transplant cohort.
    Sarwar S; Carey B; Hegarty JE; McCormick PA
    Transpl Infect Dis; 2013 Oct; 15(5):510-5. PubMed ID: 23930824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumocystis jirovecii pneumonia associated with etanercept treatment in patients with rheumatoid arthritis: a retrospective review of 15 cases and analysis of risk factors.
    Tanaka M; Sakai R; Koike R; Komano Y; Nanki T; Sakai F; Sugiyama H; Matsushima H; Kojima T; Ohta S; Ishibe Y; Sawabe T; Ota Y; Ohishi K; Miyazato H; Nonomura Y; Saito K; Tanaka Y; Nagasawa H; Takeuchi T; Nakajima A; Ohtsubo H; Onishi M; Goto Y; Dobashi H; Miyasaka N; Harigai M
    Mod Rheumatol; 2012 Nov; 22(6):849-58. PubMed ID: 22354637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contemporary use of disease-modifying drugs in the management of patients with early rheumatoid arthritis in Norway.
    Nikolaisen C; Kvien TK; Mikkelsen K; Kaufmann C; Rødevand E; Nossent JC
    Scand J Rheumatol; 2009; 38(4):240-5. PubMed ID: 19229766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications.
    O'Dell JR; Haire CE; Erikson N; Drymalski W; Palmer W; Eckhoff PJ; Garwood V; Maloley P; Klassen LW; Wees S; Klein H; Moore GF
    N Engl J Med; 1996 May; 334(20):1287-91. PubMed ID: 8609945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumocystis jirovecii Pneumonia in the Non-HIV-Infected Population.
    Avino LJ; Naylor SM; Roecker AM
    Ann Pharmacother; 2016 Aug; 50(8):673-9. PubMed ID: 27242349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate might reduce ischemic stroke in patients with rheumatoid arthritis: a population-based retrospective cohort study.
    Tam HW; Chen CM; Leong PY; Chen CH; Li YC; Wang YH; Lin LC; Chiou JY; Wei JC
    Int J Rheum Dis; 2018 Aug; 21(8):1591-1599. PubMed ID: 29372595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute exacerbation of interstitial pneumonia associated with rheumatoid arthritis during the course of treatment for Pneumocystis jirovecii pneumonia: a case report.
    Kuroda T; Takeuchi H; Nozawa Y; Sato H; Nakatsue T; Wada Y; Moriyama H; Nakano M; Narita I
    BMC Res Notes; 2016 Apr; 9():240. PubMed ID: 27113212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.